Susac syndrome is a rare inflammatory vascular endotheliopathy affecting the small vessels of the brain, eye, and ear.1,2 ...

Cyclophosphamide, arguably the most effective of the conventional immunosuppressives used for SLE, may have a rapid effect in some patients that is not well-understood and has not been studied in ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

Methods HRCT images were acquired at baseline and at 12 months in 83 participants in Scleroderma Lung Study I, a clinical trial comparing treatment with oral cyclophosphamide versus placebo. A ...

methylprednisolone 1000 mg daily × 3 days followed by high-dose oral glucocorticoids Addition of intravenous 'bolus' cyclophosphamide; use of intravenous γ-globulin; plasma exchange; rituximab?

Cerebral angiography is often used for diagnosis; however, the specificity is low ... Early recognition is important because ...

In the meantime current gene therapies remain expensive and challenging to scale up because each patient’s batch of cells has ...

The US Food and Drug Administration (FDA) has approved a 420 mg dosage strength of Hercessi (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab). Hercessi, a HER2/neu receptor antagonist, is ...

Patients with SCD who undergo hematopoietic cell transplantation face a particularly high risk of subfertility and ...

Reveal Genomics' TNBCDX predicted response rates and risk of relapse for patients on anthracycline-free neoadjuvant therapy in a retrospective validation study.

Notably, patients benefited from pembrolizumab regardless of whether they achieved a pathologic complete response (pCR), ...

We now know everybody has a donor. With posttransplant cyclophosphamide, we can now do mismatched-unrelated donors and ...